State Street Corp raised its position in Immunomedics, Inc. (NASDAQ:IMMU) by 118.2% during the first quarter, Holdings Channel reports. The institutional investor owned 3,513,549 shares of the biopharmaceutical company’s stock after buying an additional 1,903,355 shares during the period. State Street Corp’s holdings in Immunomedics were worth $22,730,000 as of its most recent filing with the SEC.

Other institutional investors have also bought and sold shares of the company. Quantitative Systematic Strategies LLC acquired a new position in Immunomedics during the first quarter worth approximately $137,000. Bank of America Corp DE increased its position in Immunomedics by 38.8% in the first quarter. Bank of America Corp DE now owns 33,707 shares of the biopharmaceutical company’s stock worth $218,000 after buying an additional 9,426 shares in the last quarter. Metropolitan Life Insurance Co. NY increased its position in Immunomedics by 3.7% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 66,049 shares of the biopharmaceutical company’s stock worth $242,000 after buying an additional 2,384 shares in the last quarter. Knott David M acquired a new position in Immunomedics during the first quarter worth approximately $294,000. Finally, First Heartland Consultants Inc. increased its position in Immunomedics by 35.3% in the first quarter. First Heartland Consultants Inc. now owns 49,800 shares of the biopharmaceutical company’s stock worth $322,000 after buying an additional 13,000 shares in the last quarter. Institutional investors own 62.10% of the company’s stock.

Shares of Immunomedics, Inc. (NASDAQ IMMU) traded down 0.427% during midday trading on Thursday, reaching $8.165. 420,915 shares of the company traded hands. Immunomedics, Inc. has a 12-month low of $2.02 and a 12-month high of $9.51. The firm’s market capitalization is $894.92 million. The company has a 50-day moving average of $8.65 and a 200 day moving average of $6.76.

WARNING: “State Street Corp Acquires 1,903,355 Shares of Immunomedics, Inc. (NASDAQ:IMMU)” was first posted by Watch List News and is owned by of Watch List News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this report can be read at https://www.watchlistnews.com/state-street-corp-acquires-1903355-shares-of-immunomedics-inc-nasdaqimmu/1470854.html.

A number of research firms have recently commented on IMMU. Cowen and Company restated an “outperform” rating and set a $15.00 price objective on shares of Immunomedics in a research note on Monday, July 24th. Zacks Investment Research upgraded shares of Immunomedics from a “sell” rating to a “buy” rating and set a $9.50 price objective for the company in a research note on Tuesday, July 11th. Wells Fargo & Company upgraded shares of Immunomedics from a “market perform” rating to an “outperform” rating in a research note on Friday, May 5th. BidaskClub downgraded shares of Immunomedics from a “buy” rating to a “hold” rating in a research note on Friday, August 4th. Finally, Jefferies Group LLC restated a “buy” rating and set a $11.00 price objective on shares of Immunomedics in a research note on Friday, July 14th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $12.00.

Immunomedics Company Profile

Immunomedics, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders and other serious diseases. Its geographic segments include United States and Europe. Its technologies allow it to create humanized antibodies that can be used either alone in unlabeled or naked form, or conjugated with radioactive isotopes, chemotherapeutics, cytokines or toxins.

Want to see what other hedge funds are holding IMMU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Immunomedics, Inc. (NASDAQ:IMMU).

Institutional Ownership by Quarter for Immunomedics (NASDAQ:IMMU)

Receive News & Ratings for Immunomedics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immunomedics Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.